Sponsor / Institution

University Hospital Tuebingen

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All Programs Therapeutics Devices

Open filtered programs

Programs

linked to organization

Strong Evidence

0 status confirmed

Details Checked

0 open data checks

Company / Institution Links

0 / 1

industry vs non-industry records

Competitive Density

Pipeline Velocity

Completion Signal

100

Programs by Stage

Phase 31

Trial / Program Status

Completed1

Modality Mix

Steroid/Anti-inflammatory1

Indication Coverage

Hearing Loss1

Sensorineural Hearing Loss1

Sudden Sensorineural Hearing Loss1

Program Types

Therapeutic1

Population Tags

adult1

sensorineural1

sudden1

unilateral1

Strong-Evidence Records

0 records

No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

1 checked · 0 open checks

Tuebingen intratympanic dexamethasone catheter SSNHL study

Details checked

Steroid/Anti-inflammatoryPhase 3Completed

Completed randomized placebo-controlled Phase 3 study of continuous two-week intratympanic dexamethasone delivery through a temporarily implanted round-window catheter after insufficient recovery from initial systemic therapy.

Data checks: institution-led-study, published-results